APTYS Pharmaceuticals News

Flux RSS des news

25-27 October 2011 : ICSE, Frankfurt (Germany) (Booth 41J45)

Aptys will be in Frankfurt for the ICSE annual meeting. Please feel free visit us at the Booth 41J45.

10-12 October 2011 : Biopartnering, London (England)

Aptys will be present at the Biopartnering.

14-15 June 2011 : SFSTP, Montpellier (France) (booth 33)

APTYS is exhibitor (booth 0033) at the 43th meeting of SFSTP.

1st April 2011 : Injectable depot formulation

APTYS offers injectable depot formulation suitable for protein delivery.

February 2011 : Certification ISO 9001

Aptys has been certified ISO 9001 - 2008 .

Desing and development of formulations and analytical methods for pharmaceutical, veterinary, cosmetical and nutraceutical products:
 consulting,
 formulation development,
 analytical development and validation,
 stability studies,
 assistance to production.



January 2011 : Aptys member of OSEO Excellence

OSEO Excellence combines 2 000 innovations and growing companies among the 77 000 French companies supported by OSEO.



Thursday 24th & Friday 25th February 2011 - Molino Stucky Hilton, Venice, Italy : Meeting Europharm SMC

Aptys will be present at the 9th international Meeting Europharm SMC.

9 December 2010 : 1ère Journée Scientifique d’ANALGESIA Partnership (Clermont-Ferrand)

Aptys will be in Clermont-Ferrand (France) for the "1ère Journée scientifique d’Analgesia Partnership".

14 December 2010 : OUTSOURCING DRUG DEVELOPMENT, Evreux (France)

Aptys will be in Evreux (France) for the Outsourcing Drug Development, Congress and Business Convention.

15-17 November 2010 : BIO-Europe 2010, Munich (Germany)

Aptys will be in Munich (Germany) for the 16th Annual International Partnering Conference Bio-Europe 2010

5-7 October 2010 : ICSE, Paris France (booth 4H79)

APTYS will be in Paris for the ICSE annual meeting. Please feel free visit us at Booth 4H79.

22-23 September 2010 : POLEPHARMA, Dreux France

APTYS will be in Dreux (France) for the POLEPHARMA Meetings.

3-6 May, 2010 : BIO, Chicago, USA (booth # 3712, France Pavilion)

APTYS will be in Chicago for the BIO annual meeting. Please feel free to visit us at Booth # 3712.

22-23 April 2010 : Europharm SNC, London, UK

APTYS will be in London for the Europharm SNC.

8-9 March 2010 : BIO Europe Spring, Barcelone, Spain

26-27 January 2010 : Drug Delivery and Formulation, Düsseldorf, Germany

23 November 2009 : Creation of Analgesia Partnership

November 2009 : Exhibitor at AAPS Los Angeles (Booth #2940)

APTYS will be in Los Angeles for the AAPS annual meeting. Please feel free to visit us at Booth 2940.

October 2009 : Exhibiting at CPhI Madrid (stand 8NE06)

APTYS will be holding a booth at CPhI/ICSE in Madrid (Stand 8NE06). We’d be happy to meet you there. Please feel fre to contact us to set up an appointment.

September 2009 : New high potency API labs

APTYS introduces its new labs dedicated to the development of highly potent products. We’d be happy to discuss your needs for the development of liquid (solutions, suspensions) and solid (tablets, granulates) dosage forms.

September 2009 : Exhibitor at Eurobio ’09

APTYS will be co-exhibiting on Stand Auvergne (#H2) at Eurobio Lille between September 23 and 25. Please feel free to contact us to set up an appointment.

June 2009 : Visitor at Bio-Connexion

APTYS will be at the event Bio-Connexion on June 18 in Paris.

April 2009 : Meet us at Bioprocess in Dusseldorf

APTYS will be attending Bioprocess International meeting in Dusseldorf Germany. We will be available at the Düsseldorf Congress Centre from April 21 to April 23. Please contact us at contact@aptys-pharmceuticals.com to setup an appointment.

December 2008 : Aptys completed a first € 500,000 financial round

This first round will contribute to strengthen the service offer of the company and to accelerate the pre clinical development of its new drug delivery technology dedicated to proteins.

Clermont-Ferrand, France, 29th of December 2008. Aptys Pharmaceuticals, a company specialized in drug delivery and formulation development raised € 500,000 in its first round of financing. The round was led by Sofimac Partners, with the contribution of SAS CACF Développement (Crédit Agricole Centre France). The funds will be dedicated on one hand to reinforce the company capacity in order to satisfy an increasing demand from customers in the field of formulation R&D and on the other hand to continue the development of a new injectable formulation suitable for the administration of therapeutic proteins.

« This first round is the result of a collective work which demonstrates that our economical mix model can be successful» says François Boutignon, president of Aptys Pharmaceuticals. « Indeed, Aptys grew on the basis of its know-how and expertise dedicated to its pharmaceutical and biotech customers as well as to its own developments. We are glad to have found financial partners who recognize the pertinence of our strategy and agree to follow us while we keep the control of corporate development».

October 2008 : Exhibitor at Drug Delivery Partnerships 2008 in Barcelona

APTYS Pharmaceuticals will be holding a booth at the European Drug Delivery Partnerships 2008 Conference.

October 2008 : Exhibitor at EuroBio 2008 in Paris

APTYS Pharmaceuticals will be holding a booth at Eurobio 2008 located at the Auvergne BioCluster site. APTYS will also be present for the EuroBIOpartnering event.

July 2008 : APTYS signed contracts with 2 major French pharmaceutical companies

APTYS Pharmaceuticals signed contracts with 2 major French pharmaceutical companies

July 2008 : APTYS is expanding its analytical facility

APTYS Pharmaceuticals moved its analytical facility to a 107 sqm at Biopole Clermont-Limagne. This move will allow us to increase our reactivity to our customers.

June 2008 : APTYS signed a contract with a major pharmaceutical group

APTYS Pharmaceuticals signed a contact with one of the world’s leading pharmaceutical company.

May 2008 : APTYS strengthened its team.

APTYS Pharmaceuticals strengthened it steam with the recruitment of a project director and an analytical chemist.

March 2008 : Exhibitor at Biosquare 2008 in Basel

APTYS Pharmaceuticals will be holding one-to-one business meetings in Basel at the Biosquare 2008 conference.

January 2008 : APTYS strenghtened its team

APTYS Pharmaceuticals hired a pharmacist to serve as Project Leader Formulation

October 2007 : Exhibitor at EuroBio 2007, Lille

APTYS Pharmaceuticals will be holding a booth at Eurobio 2007 located at the Auvergne BioCluster site. APTYS will also be present for the EuroBIOpartnering event.

September 2007 : A product developed on the basis of APTYS’ ADHAPT® launched on the French market

A product based on the ADHAPT® was approved in 2006 and launched in 2007. This product is now in phase III in the USA.

May 2007 : A product based on APTYS’BI-GELtechnology commences Phase III in the USA.

A product based on the BI-GEL technology commences Clinical phase III in the USA.

April 2007 : Presentation at BioProcess International Meeting 2007 in Paris

APTYS Pharmaceuticals will present its progress with one of its internal research programs in a poster entitled "Assessment of a buccal formulation for insulin delivery".

October 2006 : Exhibitor at CPhI 2006 in Paris

APTYS Pharmaceuticals will be holding a booth at CPhI 2006.

October 2006 : Exhibitor at EuroBio 2006 in Paris

APTYS Pharmaceuticals will be holding a booth at Eurobio 2006 located at the Auvergne BioCluster site. APTYS will also be present for the EuroBIOpartnering event.

June 2006 : Exhibitor at BIO 2005 in Philadelphia

APTYS Pharmaceuticals will be holding a booth at BIO.

May 2005 : APTYS has signed a contract of collaboration with Labiopharm

APTYS Pharmaceuticals will use its patented technologies in order to formulate drugs from Labiopharm portfolio.

June 2005 : Presentation at the Controlled Release Society Meeting in Miami

APTYS Pharmaceuticals will present a poster entitled "Development of a Transdermal Gel of Testosterone based on the BI-GEL technology, in vitro results" (poster)

March 2005 : Exhibitor at the Biopharmos 2005 in Monaco

APTYS Pharmaceuticals will be holding a booth at Biopharmos 2005.

January 2005 : Exhibitor at the Drug Delivery Partnerships 2005 in San Diego, CA

APTYS Pharmaceuticals will be holding a booth at the DDP conference.

2004 : APTYS wins the price "Entreprendre en France"

APTYS Pharmaceuticals wins the price "Entreprendre en France"

2004 : APTYS gets the status of Young Innovative Company

APTYS Pharmaceuticals gets the status of Young Innovative Company delivered by the French Government to promote French biotech companies.

January 2004 : Exhibitor at the Drug Delivery Partnerships in Beverly Hills, CA

APTYS Pharmaceuticals will be holding a booth at the DDP 2004 conference.

2003 : APTYS has signed a contract of collaboration with a Dutch pharmaceutical company

APTYS Pharmaceuticals has signed a contract of collaboration with a Dutch pharmaceutical company where APTYS will develop new generic "plus" products

2003 : APTYS has signed a contract with a major generic company

APTYS Pharmaceuticals has signed a contract with a major generic company

2003 : APTYS received the price "réussissez votre création en Auvergne"

APTYS Pharmaceuticals received the price "Réussissez votre création en Auvergne" from Banque Populaire du Massif Central

June 2003 : Presentation at the Drug Delivery Partnerships 2003 in Cologne, Germany

APTYS Pharmaceuticals will present a poster entitled "Development of a bioadhesive tablets, Adhapt: a potential tool for polypeptide administration"

2002 : APTYS has signed a contract of collaboration with Ardana

APTYS Pharmaceuticals has signed a contract of collaboration with Ardana Bioscience where APTYS will use its patented technologies in order to formulate drugs from the Ardana portfolio